| __timestamp | Eli Lilly and Company | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4932500000 | 9216000000 |
| Thursday, January 1, 2015 | 5037200000 | 8296000000 |
| Friday, January 1, 2016 | 5654900000 | 10044000000 |
| Sunday, January 1, 2017 | 6070200000 | 11560000000 |
| Monday, January 1, 2018 | 4681700000 | 10558000000 |
| Tuesday, January 1, 2019 | 4721200000 | 9351000000 |
| Wednesday, January 1, 2020 | 5483300000 | 8933000000 |
| Friday, January 1, 2021 | 7312800000 | 8284000000 |
| Saturday, January 1, 2022 | 6629800000 | 7952000000 |
| Sunday, January 1, 2023 | 7082200000 | 8200000000 |
| Monday, January 1, 2024 | 8418299999 | 8480000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, cost management is crucial for maintaining competitive advantage. This analysis compares the cost of revenue for Eli Lilly and Company and Teva Pharmaceutical Industries Limited from 2014 to 2023. Over this period, Eli Lilly's cost of revenue increased by approximately 44%, peaking in 2021. In contrast, Teva's cost of revenue saw a decline of about 14%, with the highest costs recorded in 2017.
This comparison highlights the diverse strategies employed by these pharmaceutical leaders in managing their operational expenses over the past decade.
Analyzing Cost of Revenue: Eli Lilly and Company and GSK plc
Cost Insights: Breaking Down Eli Lilly and Company and Pfizer Inc.'s Expenses
Cost of Revenue Comparison: Eli Lilly and Company vs Neurocrine Biosciences, Inc.
Cost of Revenue: Key Insights for Eli Lilly and Company and BeiGene, Ltd.
Gross Profit Trends Compared: Eli Lilly and Company vs Teva Pharmaceutical Industries Limited
Eli Lilly and Company vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Eli Lilly and Company and Bausch Health Companies Inc.'s Expenses
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.